Shakhawath Hossain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shakhawath Hossain has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Per Larsson
Department of Pharmacy Uppsala University Uppsala Sweden
7 shared publications - Xiongbiao Chen
Division of Biomedical Engineering, University of Saskatchewan, Canada
7 shared publications - Madlen Hubert
Department of Pharmacy, Uppsala University, Uppsala, Sweden
4 shared publications - Aleksei Kabedev
Department of Pharmacy, Uppsala University, Uppsala Biomedical Center
3 shared publications Christel A.S. Bergström
Department of Pharmacy, Uppsala University, Uppsala 751 23, Sweden; Uppsala Antibiotic Center, Uppsala University, Uppsala, Sweden; The Swedish Drug Delivery Center (SweDeliver), Uppsala University, Uppsala 751 23, Sweden
3 shared publications- D. J. Bergstrom
University of Saskatchewan
3 shared publications
Latest Publications
- Open Access
- 16 August 2026
- Published by Elsevier in International Journal of Pharmaceutics: X
- Vol. 12
Self-assembly of sodium caprate in simulated intestinal fluids and with a therapeutic peptide: A small-angle neutron scattering study
- 16 August 2026
- Published by Elsevier in International Journal of Pharmaceutics: X
- Vol. 12
Open AccessSelf-assembly of sodium caprate in simulated intestinal fluids and with a therapeutic peptide: A small-angle neutron scattering study
- 16 July 2026
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 23 (8) , 4273-4287
In-Depth Comparison of Fasted State Simulated Intestinal Fluid (FaSSIF) Versions via NMR Spectroscopy and Complementary Methods
Efficient screening methods in the early drug development stage are key to quickly finding promising drug candidates. Solutions simulating conditions in the small intestine, the main absorption region for orally administered drugs, such as FaSSIF-V2 and V3, are essential. Updated versions aim to better mimic the natural environment with modified concentrations of the main components, taurocholate and lecithin, or inclusion of oxidation products. Here, we use NMR spectroscopy to investigate the aggregation behavior and interactions between drugs and/or polymers with the components in FaSSIF-V2 and -V3 on a molecular level. BCS-class II compounds carbamazepine, ketoconazole, and efavirenz served as model drugs. We found that while the individual FaSSIF versions alone showed a different apparent diffusion, addition of either drugs or polymers evened out these differences. The more complex composition of FaSSIF-V3 results in a higher signal overlap in the NMR spectra. Furthermore, the simultaneous presence of similar chemical entities with different solubilities is challenging for the DOSY analysis, as one NMR signal contains differently diffusing species. NMR spectroscopy complemented by solubility and DLS measurements as well as MD simulations showed that the different diffusion behavior of FaSSIF-V2 and -V3 is indeed a result of the solubility variations of the lecithin-like molecules. Furthermore, it was observed that all model drugs behaved differently in the FaSSIF media, spanning behavior from barely interacting (carbamazepine) to drug molecules in fast exchange between bile colloids and free solution (ketoconazole) to molecules fully incorporated into the bile aggregates (efavirenz). Although FaSSIF-V3 mimics the natural environment better, FaSSIF-V2 behaved overall more robustly across the different analytical tools and the molecular-level picture obtained for the individual media was overall similar.
- 16 July 2026
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 23 (8) , 4273-4287
In-Depth Comparison of Fasted State Simulated Intestinal Fluid (FaSSIF) Versions via NMR Spectroscopy and Complementary Methods
Efficient screening methods in the early drug development stage are key to quickly finding promising drug candidates. Solutions simulating conditions in the small intestine, the main absorption region for orally administered drugs, such as FaSSIF-V2 and V3, are essential. Updated versions aim to better mimic the natural environment with modified concentrations of the main components, taurocholate and lecithin, or inclusion of oxidation products. Here, we use NMR spectroscopy to investigate the aggregation behavior and interactions between drugs and/or polymers with the components in FaSSIF-V2 and -V3 on a molecular level. BCS-class II compounds carbamazepine, ketoconazole, and efavirenz served as model drugs. We found that while the individual FaSSIF versions alone showed a different apparent diffusion, addition of either drugs or polymers evened out these differences. The more complex composition of FaSSIF-V3 results in a higher signal overlap in the NMR spectra. Furthermore, the simultaneous presence of similar chemical entities with different solubilities is challenging for the DOSY analysis, as one NMR signal contains differently diffusing species. NMR spectroscopy complemented by solubility and DLS measurements as well as MD simulations showed that the different diffusion behavior of FaSSIF-V2 and -V3 is indeed a result of the solubility variations of the lecithin-like molecules. Furthermore, it was observed that all model drugs behaved differently in the FaSSIF media, spanning behavior from barely interacting (carbamazepine) to drug molecules in fast exchange between bile colloids and free solution (ketoconazole) to molecules fully incorporated into the bile aggregates (efavirenz). Although FaSSIF-V3 mimics the natural environment better, FaSSIF-V2 behaved overall more robustly across the different analytical tools and the molecular-level picture obtained for the individual media was overall similar.
- Open Access
- 16 July 2026
- Published by Elsevier in SSRN Electronic Journal
Interactions of GLP-1 peptide analogues with the permeation enhancer sodium caprate: Effect of lipidation and implications for oral delivery
Oral peptide delivery increasingly relies on permeation enhancers (PEs), but how enhancer self-assembly couples to peptide self-assembly and co-assembly remains poorly understood. Here, we investigated the interactions between glucagon-like peptide-1 (GLP-1) analogues and the permeation enhancer sodium caprate (C10), with emphasis on how peptide lipidation and enhancer self-assembly control peptide availability for absorption. A non-lipidated analogue (J211), two mono-lipidated analogues (J229 and semaglutide), and a bis-lipidated analogue (MEDI7219) were characterized by 1H NMR spectroscopy, diffusion NMR, small-angle X-ray scattering (SAXS), circular dichroism (CD) and all-atom molecular dynamics (MD) simulations. In deuterated buffer, the peptides formed distinct oligomeric states with the size ranking semaglutide > J211 > J229 ≈ MEDI7219, while retaining predominantly α-helical secondary structure. C10 underwent a marked colloidal transition with the formulation conditions, forming non-spherical micelles at pD 8.5 and vesicular aggregates at pD 7.4 in fasted-state simulated intestinal fluid (FaSSIF-V2). Under alkaline micellar conditions, C10 associated with all peptides and remodeled the larger oligomers, J211 and semaglutide, by loosening peptide-peptide packing without major changes in global dimensions or helicity. Under near-neutral biorelevant conditions, peptide-C10 co-assembly became strongly peptide dependent. MEDI7219 showed the weakest association with C10 aggregates and retained the largest unbound fraction, whereas semaglutide and J229 had the most bound fraction. This ranking correlated to previously observed intestinal absorption ranking in vivo. These results show that peptide absorption is impacted by the coupled equilibria between peptide self-assembly, enhancer colloidal state, and peptide bound versus unbound fractions.
- 16 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessInteractions of GLP-1 peptide analogues with the permeation enhancer sodium caprate: Effect of lipidation and implications for oral delivery
Oral peptide delivery increasingly relies on permeation enhancers (PEs), but how enhancer self-assembly couples to peptide self-assembly and co-assembly remains poorly understood. Here, we investigated the interactions between glucagon-like peptide-1 (GLP-1) analogues and the permeation enhancer sodium caprate (C10), with emphasis on how peptide lipidation and enhancer self-assembly control peptide availability for absorption. A non-lipidated analogue (J211), two mono-lipidated analogues (J229 and semaglutide), and a bis-lipidated analogue (MEDI7219) were characterized by 1H NMR spectroscopy, diffusion NMR, small-angle X-ray scattering (SAXS), circular dichroism (CD) and all-atom molecular dynamics (MD) simulations. In deuterated buffer, the peptides formed distinct oligomeric states with the size ranking semaglutide > J211 > J229 ≈ MEDI7219, while retaining predominantly α-helical secondary structure. C10 underwent a marked colloidal transition with the formulation conditions, forming non-spherical micelles at pD 8.5 and vesicular aggregates at pD 7.4 in fasted-state simulated intestinal fluid (FaSSIF-V2). Under alkaline micellar conditions, C10 associated with all peptides and remodeled the larger oligomers, J211 and semaglutide, by loosening peptide-peptide packing without major changes in global dimensions or helicity. Under near-neutral biorelevant conditions, peptide-C10 co-assembly became strongly peptide dependent. MEDI7219 showed the weakest association with C10 aggregates and retained the largest unbound fraction, whereas semaglutide and J229 had the most bound fraction. This ranking correlated to previously observed intestinal absorption ranking in vivo. These results show that peptide absorption is impacted by the coupled equilibria between peptide self-assembly, enhancer colloidal state, and peptide bound versus unbound fractions.
- Open Access
- 11 May 2026
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 28 (22) , 13514-13525
Aggregation behavior of sodium caprate under different pH, concentration, and intestinal fluid conditions: a coarse-grained molecular dynamics study comparing Martini 2 and Martini 3
Sodium caprate (C10) is an ionizable amphiphile whose self-assembly behavior in aqueous environments is strongly modulated by pH and concentration.
- 11 May 2026
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 28 (22) , 13514-13525
Open AccessAggregation behavior of sodium caprate under different pH, concentration, and intestinal fluid conditions: a coarse-grained molecular dynamics study comparing Martini 2 and Martini 3
Sodium caprate (C10) is an ionizable amphiphile whose self-assembly behavior in aqueous environments is strongly modulated by pH and concentration.
- Open Access
- 7 January 2026
- Published by Royal Society of Chemistry (RSC) in Polymer Chemistry
- Vol. 17 (6) , 655-669
Designing jasmine lactone copolymer micelles for drug delivery: influence of ionic group density and chain length
The effect of anionic functionalization on drug encapsulation, release, and cytotoxicity of poly-jasmine lactone micelles.
- 7 January 2026
- Published by Royal Society of Chemistry (RSC) in Polymer Chemistry
- Vol. 17 (6) , 655-669
Open AccessDesigning jasmine lactone copolymer micelles for drug delivery: influence of ionic group density and chain length
The effect of anionic functionalization on drug encapsulation, release, and cytotoxicity of poly-jasmine lactone micelles.
- Open Access
- 31 October 2025
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 258, 115240
Molecular dynamics simulations of a hexagonal liquid crystal phase to study drug partitioning and release mechanisms
- 31 October 2025
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 258, 115240
Open AccessMolecular dynamics simulations of a hexagonal liquid crystal phase to study drug partitioning and release mechanisms
- Open Access
- 22 August 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-18
Machine learning framework for investigating nano- and micro-scale particle diffusion in colonic mucus
Biosimilar artificial mucus models that mimic native mucus facilitate efficient, lab-based drug diffusion studies, addressing the costly and challenging preclinical phase of drug development, especially for nano- and micro-scale particle-based colonic drug delivery. This study presents a machine-learning-driven framework that integrates microrheological features into diffusional fingerprinting to characterize nano- and micro-scale particle diffusion patterns in mucus and assess the effect of mucus microrheology on such movements. We investigated the diffusion of fluorescent-labeled polystyrene particles in native pig mucus and two artificial mucus models. Particles (100, 200, and 1000 nm in diameter) with carboxylate- or amine-modified surfaces were tracked during passive diffusion. From each particle trajectory, 20 features —including microrheology-based parameters— were extracted. Based on these features, seven supervised machine learning models were applied to classify or identify similarities among mucus hydrogels. Of these, gradient boosting achieved the highest accuracy. SHapley Additive exPlanations analysis identified creep compliance as the most influential feature in distinguishing the mucus models. In native mucus, smaller negatively charged nanoparticles exhibited the highest mobility, with fewer particles being in the immobile and subdiffusive states. Microrheology data further indicated that larger particles experienced greater restriction owing to the elastic properties of native mucus. In contrast, smaller particles interacted more with the viscous liquid phase. A comprehensive feature-wide analysis revealed that hydroxyethyl cellulose (HEC)-based artificial mucus more closely resembled native pig mucus than the polyacrylic acid-based model. In conclusion, the machine-learning-driven fingerprinting approach, incorporating microrheological features, successfully differentiated the microstructural characteristics and rheological properties of the three mucus models. It also supported the selection of HEC-based artificial mucus as a viable substitute for native colonic mucus. Graphical abstract
- 22 August 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-18
Open AccessMachine learning framework for investigating nano- and micro-scale particle diffusion in colonic mucus
Biosimilar artificial mucus models that mimic native mucus facilitate efficient, lab-based drug diffusion studies, addressing the costly and challenging preclinical phase of drug development, especially for nano- and micro-scale particle-based colonic drug delivery. This study presents a machine-learning-driven framework that integrates microrheological features into diffusional fingerprinting to characterize nano- and micro-scale particle diffusion patterns in mucus and assess the effect of mucus microrheology on such movements. We investigated the diffusion of fluorescent-labeled polystyrene particles in native pig mucus and two artificial mucus models. Particles (100, 200, and 1000 nm in diameter) with carboxylate- or amine-modified surfaces were tracked during passive diffusion. From each particle trajectory, 20 features —including microrheology-based parameters— were extracted. Based on these features, seven supervised machine learning models were applied to classify or identify similarities among mucus hydrogels. Of these, gradient boosting achieved the highest accuracy. SHapley Additive exPlanations analysis identified creep compliance as the most influential feature in distinguishing the mucus models. In native mucus, smaller negatively charged nanoparticles exhibited the highest mobility, with fewer particles being in the immobile and subdiffusive states. Microrheology data further indicated that larger particles experienced greater restriction owing to the elastic properties of native mucus. In contrast, smaller particles interacted more with the viscous liquid phase. A comprehensive feature-wide analysis revealed that hydroxyethyl cellulose (HEC)-based artificial mucus more closely resembled native pig mucus than the polyacrylic acid-based model. In conclusion, the machine-learning-driven fingerprinting approach, incorporating microrheological features, successfully differentiated the microstructural characteristics and rheological properties of the three mucus models. It also supported the selection of HEC-based artificial mucus as a viable substitute for native colonic mucus. Graphical abstract
- Open Access
- 18 March 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Molecular dynamic simulations of a hexagonal liquid crystalline phase to study drug partitioning and release mechanisms
Liquid crystalline nanoparticles (LCNPs), such as hexosomes (HII), can enhance lipid nanoparticle-mediated drug delivery by improving drug absorption, solubility, and chemical stability. Additionally, LCNPs can be tailored to optimize their function in specific biological environments by incorporating non-external-linker lipids into the HII system lipid composition. In this study, we constructed an HII model system composed of a 90:10 phytantriol:farnesol ratio and performed all-atom molecular dynamics simulations. The simulations demonstrated that the model remained stable across various water-to-lipid ratios, and the impact of the water-to-lipid ratio on the HII structural properties was consistent with previous experimental observations. We then used this model to investigate the localization and interactions of two drug molecules: vancomycin and clarithromycin. The results show that the highly lipophilic clarithromycin predominantly associates with the lipid phase, whereas vancomycin, due to its combination of hydrophobic and hydrophilic residues, tends to localize at the water-lipid interface, interacting with both phases. We also constructed an HII system with repeating HII units enclosed within Pluronic F127 polymers. Simulations revealed that the F127 polymers interact with the lipid phases at the HII interface region, facilitating excess water permeation into the HII phase system. To investigate the initial surface release mechanism of the drug molecules, we performed umbrella sampling (US) simulations. The energy profiles from the umbrella sampling indicate that polymer-lipid-water interactions at the HII interface reduce the energy barrier for drug release, making the release of vancomycin easier compared to clarithromycin. Our in vitro release study further confirmed that vancomycin exhibited higher release compared to clarithromycin. Overall, the model developed in this study provided important molecular-level insights into drug loading, partitioning, and release kinetics from the HII phase system, enabling the design of effective drug delivery formulations.
- 18 March 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessMolecular dynamic simulations of a hexagonal liquid crystalline phase to study drug partitioning and release mechanisms
Liquid crystalline nanoparticles (LCNPs), such as hexosomes (HII), can enhance lipid nanoparticle-mediated drug delivery by improving drug absorption, solubility, and chemical stability. Additionally, LCNPs can be tailored to optimize their function in specific biological environments by incorporating non-external-linker lipids into the HII system lipid composition. In this study, we constructed an HII model system composed of a 90:10 phytantriol:farnesol ratio and performed all-atom molecular dynamics simulations. The simulations demonstrated that the model remained stable across various water-to-lipid ratios, and the impact of the water-to-lipid ratio on the HII structural properties was consistent with previous experimental observations. We then used this model to investigate the localization and interactions of two drug molecules: vancomycin and clarithromycin. The results show that the highly lipophilic clarithromycin predominantly associates with the lipid phase, whereas vancomycin, due to its combination of hydrophobic and hydrophilic residues, tends to localize at the water-lipid interface, interacting with both phases. We also constructed an HII system with repeating HII units enclosed within Pluronic F127 polymers. Simulations revealed that the F127 polymers interact with the lipid phases at the HII interface region, facilitating excess water permeation into the HII phase system. To investigate the initial surface release mechanism of the drug molecules, we performed umbrella sampling (US) simulations. The energy profiles from the umbrella sampling indicate that polymer-lipid-water interactions at the HII interface reduce the energy barrier for drug release, making the release of vancomycin easier compared to clarithromycin. Our in vitro release study further confirmed that vancomycin exhibited higher release compared to clarithromycin. Overall, the model developed in this study provided important molecular-level insights into drug loading, partitioning, and release kinetics from the HII phase system, enabling the design of effective drug delivery formulations.
- Open Access
- 9 October 2024
- Published by Elsevier in Chemistry and Physics of Lipids
- Vol. 265, 105448
Molecular dynamics simulations of lipid composition and its impact on structural and dynamic properties of skin membrane
- 9 October 2024
- Published by Elsevier in Chemistry and Physics of Lipids
- Vol. 265, 105448
Open AccessMolecular dynamics simulations of lipid composition and its impact on structural and dynamic properties of skin membrane
- 8 September 2023
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 20 (10) , 4800-4801
Voices in Molecular Pharmaceutics: Meet Dr. Shakhawath Hossain, a Computational Pharmaceutics Expert Seeking to Improve Delivery of Poorly Permeable Molecules
- 8 September 2023
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 20 (10) , 4800-4801
Voices in Molecular Pharmaceutics: Meet Dr. Shakhawath Hossain, a Computational Pharmaceutics Expert Seeking to Improve Delivery of Poorly Permeable Molecules